Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Shogaol, an aromatic constituent of ginger, is the chain-dehydroxylated analog of 6-Gingerol. It exhibits a range of pharmacological activities, including inhibition of spontaneous motor activity, antipyretic and analgesic effects, and prolonged hexobarbital-induced sleeping time. Additionally, 6-Shogaol demonstrates potent antitussive activity and influences the cortical EEG.

555-66-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 555-66-8 Structure
  • Basic information

    1. Product Name: 6-Shogaol
    2. Synonyms: (E)-1-(4-Hydroxy-3-methoxy-phenyl)dec-4-en-3-one;6-SHOGAOL;SHOGAOL;SHOGAOL, 6-;4-Decen-3-one, 1-(4-hydroxy-3-methoxyphenyl);6-Shagaol;1-(3-Methoxy-4-hydroxyphenyl)-4-decene-3-one;1-(4-Hydroxy-3-methoxyphenyl)-4-decen-3-one
    3. CAS NO:555-66-8
    4. Molecular Formula: C17H24O3
    5. Molecular Weight: 276.37
    6. EINECS: N/A
    7. Product Categories: Miscellaneous Natural Products;The group of Ginerols;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract
    8. Mol File: 555-66-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 427.5 °C at 760 mmHg
    3. Flash Point: 150.3 °C
    4. Appearance: /
    5. Density: 1.033 g/cm3
    6. Vapor Pressure: 6.55E-08mmHg at 25°C
    7. Refractive Index: 1.521
    8. Storage Temp.: 2-8°C
    9. Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
    10. PKA: 10.01±0.20(Predicted)
    11. BRN: 2056098
    12. CAS DataBase Reference: 6-Shogaol(CAS DataBase Reference)
    13. NIST Chemistry Reference: 6-Shogaol(555-66-8)
    14. EPA Substance Registry System: 6-Shogaol(555-66-8)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 22
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 555-66-8(Hazardous Substances Data)

555-66-8 Usage

Uses

Used in Pharmaceutical Applications:
6-Shogaol is used as a therapeutic agent for its various pharmacological properties, such as inhibition of spontaneous motor activity, antipyretic and analgesic effects, and prolonged hexobarbital-induced sleeping time. Its potent antitussive activity and influence on the cortical EEG also contribute to its potential use in the development of medications for various conditions.
Used in Nutraceutical Applications:
6-Shogaol is used as a nutraceutical ingredient due to its potential health benefits, including its anti-inflammatory, antioxidant, and antimicrobial properties. These properties make it a valuable addition to dietary supplements and functional foods aimed at promoting overall health and well-being.
Used in Cosmetic Applications:
6-Shogaol is used as an active ingredient in the cosmetic industry for its potential anti-inflammatory and antioxidant properties. These characteristics can be beneficial in the development of skincare products designed to improve skin health, reduce inflammation, and protect against environmental stressors.
Used in Food and Beverage Industry:
6-Shogaol is used as a flavor enhancer and preservative in the food and beverage industry. Its unique aromatic properties can add depth and complexity to various food products, while its antimicrobial properties can help extend shelf life and maintain product quality.

Anticancer Research

6-Shogaol is the dehydrated product of 6-gingerol, extracted from the rhizome ofginger. Treatment of HCC cell line with 6-shogaol resulted in cells with apoptoticphenotypes, which showed signs of cell and nuclear shrinkage as well as substantialchromatin condensation. De-phosphorylation of PERK and activation of theexpression of CHOP initiate caspase cascade reaction inducing apoptosis inHCC. Two-dimensional gel electrophoretic analysis of proteome revealed that in response to the treatment with 6-shogaol, a significant stimulation was observed inproteins related to the ER stress, signifying that apoptosis induced by 6-shogoal didinvolve ER stress. Cells showed marked rise in the UPR target expression, HSP70,Grp94, Grp78/Bip and the other ER chaperones on exposure to 6-shogoal in a time-dependentmanner, which elicited activation of caspase-3 and degradation of polyADP ribose polymerase (PARP). Various ER chaperone proteins improve adaptationof cancer cells to hypoxic environment and aid in developing resistance againstanticancer therapy (Zorzi and Bonvini 2011; Urra et al. 2016). Screening of specificinhibitors of Grp78 as antitumour agents (Hu et al. 2012; Liu et al. 2013; Venkatesanet al. 2015) implies that inhibition of Grp78/Bip is a very promising anticancerstrategy. HCC cells are selectively killed by 6-shogaol in the absence of anynoticeable toxic consequence on normal healthy cells and very little toxicity asstudied on SMMC7721 xenograft mice. Administration of 6-shogaol and salubrinaltogether for distinct time intervals resulted in significant increase in ER stress in thecell. It appears that 6-shogaol in combination with salubrinal has great therapeuticvalue against various malignancies including HCC (Hu et al. 2012).

Check Digit Verification of cas no

The CAS Registry Mumber 555-66-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 5 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 555-66:
(5*5)+(4*5)+(3*5)+(2*6)+(1*6)=78
78 % 10 = 8
So 555-66-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H24O3/c1-3-4-5-6-7-8-15(18)11-9-14-10-12-16(19)17(13-14)20-2/h7-8,10,12-13,19H,3-6,9,11H2,1-2H3/b8-7+

555-66-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (39303)  [6]-Shogaol  analytical standard

  • 555-66-8

  • 39303-10MG

  • 6,165.90CNY

  • Detail

555-66-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one

1.2 Other means of identification

Product number -
Other names Shogaol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:555-66-8 SDS

555-66-8Synthetic route

ethyl 5-(4-hydroxy-3-methoxyphenyl)-3-oxopentanoate

ethyl 5-(4-hydroxy-3-methoxyphenyl)-3-oxopentanoate

hexanal
66-25-1

hexanal

[6]-shogaol
555-66-8

[6]-shogaol

Conditions
ConditionsYield
With sodium hydroxide In dimethyl sulfoxide at 0℃; for 0.5h;75%
Conditions
ConditionsYield
With potassium fluoride; C50H34F12O6 In toluene at 25℃; for 192h; Inert atmosphere; Resolution of racemate; enantioselective reaction;A n/a
B 48%
Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene Heating;
With potassium carbonate; methyl iodide In methanol at 20℃; for 48h;
hexanal
66-25-1

hexanal

zingerone

zingerone

[6]-shogaol
555-66-8

[6]-shogaol

Conditions
ConditionsYield
With potassium hydroxide; diethyl ether
Dehydrozingerone
1080-12-2

Dehydrozingerone

[6]-shogaol
555-66-8

[6]-shogaol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: H2 / Raney-Ni / -10 °C
2: (i) nBuLi, iPr2NH, THF, (ii) /BRN= 1209232/
3: TiCl4 / CH2Cl2 / -78 °C
4: TsOH / benzene / Heating
View Scheme
Multi-step reaction with 3 steps
1: sodium hydride / Reflux
2: hydrogen / acetone
3: sodium hydroxide / dimethyl sulfoxide / 0.5 h / 0 °C
View Scheme
4-(4-hydroxy-3-methoxyphenyl)-2-butanone
122-48-5

4-(4-hydroxy-3-methoxyphenyl)-2-butanone

[6]-shogaol
555-66-8

[6]-shogaol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: (i) nBuLi, iPr2NH, THF, (ii) /BRN= 1209232/
2: TiCl4 / CH2Cl2 / -78 °C
3: TsOH / benzene / Heating
View Scheme
2-Methoxy-1-trimethylsilanyloxy-4-(3-trimethylsilanyloxy-but-3-enyl)-benzene
60101-00-0

2-Methoxy-1-trimethylsilanyloxy-4-(3-trimethylsilanyloxy-but-3-enyl)-benzene

[6]-shogaol
555-66-8

[6]-shogaol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: TiCl4 / CH2Cl2 / -78 °C
2: TsOH / benzene / Heating
View Scheme
vanillin
121-33-5

vanillin

[6]-shogaol
555-66-8

[6]-shogaol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: BF3-Et2O / CH2Cl2
2: H2 / Raney-Ni / -10 °C
3: (i) nBuLi, iPr2NH, THF, (ii) /BRN= 1209232/
4: TiCl4 / CH2Cl2 / -78 °C
5: TsOH / benzene / Heating
View Scheme
[6]-shogaol
555-66-8

[6]-shogaol

1-(4'-hydroxy-3'-methoxyphenyl)-4-decen-3-ol

1-(4'-hydroxy-3'-methoxyphenyl)-4-decen-3-ol

Conditions
ConditionsYield
Stage #1: [6]-shogaol With cerium(III) chloride heptahydrate In methanol at -78℃; for 0.166667h;
Stage #2: With methanol; sodium tetrahydroborate at -78℃; for 0.5h;
100%
[6]-shogaol
555-66-8

[6]-shogaol

[6]-paradol
27113-22-0

[6]-paradol

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran at 20℃;98%
[6]-shogaol
555-66-8

[6]-shogaol

O-acetylsalicyloyl chloride
5538-51-2

O-acetylsalicyloyl chloride

6-shogaol aspirinate

6-shogaol aspirinate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0℃; for 2h;93%
methanol
67-56-1

methanol

[6]-shogaol
555-66-8

[6]-shogaol

5-methoxy-1-(4'-hydroxy-3'-methoxyphenyl)decan-3-one

5-methoxy-1-(4'-hydroxy-3'-methoxyphenyl)decan-3-one

Conditions
ConditionsYield
With sodium methylate at 0℃; for 4h; Michael Addition;90%
N-acetylcystein
616-91-1

N-acetylcystein

[6]-shogaol
555-66-8

[6]-shogaol

5-N-acetylcysteinyl-[6]-shogaol

5-N-acetylcysteinyl-[6]-shogaol

Conditions
ConditionsYield
With sodium hydrogencarbonate In methanol; water at 20℃; for 72h; Reagent/catalyst; Solvent; Temperature; Michael Addition;80%
GLUTATHIONE
70-18-8

GLUTATHIONE

[6]-shogaol
555-66-8

[6]-shogaol

5-glutathiol-[6]-shogaol

5-glutathiol-[6]-shogaol

Conditions
ConditionsYield
With sodium hydrogencarbonate In methanol; water at 20℃; for 3h; Michael Addition;80%
[6]-shogaol
555-66-8

[6]-shogaol

thymin
65-71-4

thymin

1-(1-(4-hydroxy-3-methoxyphenyl)-3-oxodecan-5-yl)-5-methylpyrimidine-2,4-(1H,3H)-dione

1-(1-(4-hydroxy-3-methoxyphenyl)-3-oxodecan-5-yl)-5-methylpyrimidine-2,4-(1H,3H)-dione

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide at 20℃; for 24h; Michael Addition;67%
[6]-shogaol
555-66-8

[6]-shogaol

(1E,4E)-1-(4'-hydroxy-3'-methoxyphenyl)-deca-1,4-dien-3-one

(1E,4E)-1-(4'-hydroxy-3'-methoxyphenyl)-deca-1,4-dien-3-one

Conditions
ConditionsYield
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In tetrahydrofuran at 0 - 20℃; for 3.5h;62%
L-Cysteine
52-90-4

L-Cysteine

[6]-shogaol
555-66-8

[6]-shogaol

5-cysteinyl-[6]-shogaol

5-cysteinyl-[6]-shogaol

Conditions
ConditionsYield
With sodium hydrogencarbonate In methanol; water at 20℃; for 24h; Michael Addition;60%
[6]-shogaol
555-66-8

[6]-shogaol

sodium thiomethoxide
5188-07-8

sodium thiomethoxide

5-methylthio-1-(4'-hydroxy-3'-methoxyphenyl)decan-3-one

5-methylthio-1-(4'-hydroxy-3'-methoxyphenyl)decan-3-one

Conditions
ConditionsYield
In tetrahydrofuran; water at 20℃; for 6h; Michael Addition;60%
3-methylpyridin-2-ylamine
1603-40-3

3-methylpyridin-2-ylamine

[6]-shogaol
555-66-8

[6]-shogaol

1-(4-hydroxy-3-methoxyphenyl)-5-(3-methylpyridin-2-ylamino)decan-3-one

1-(4-hydroxy-3-methoxyphenyl)-5-(3-methylpyridin-2-ylamino)decan-3-one

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide at 20℃; for 24h; Michael Addition;57%
2-Amino-4-methylpyridine
695-34-1

2-Amino-4-methylpyridine

[6]-shogaol
555-66-8

[6]-shogaol

1-(4-hydroxy-3-methoxyphenyl)-5-(4-methylpyridin-2-ylamino)decan-3-one

1-(4-hydroxy-3-methoxyphenyl)-5-(4-methylpyridin-2-ylamino)decan-3-one

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide at 20℃; for 24h; Michael Addition;54%
(5-methyl-pyridin-2-yl)amine
1603-41-4

(5-methyl-pyridin-2-yl)amine

[6]-shogaol
555-66-8

[6]-shogaol

1-(4-hydroxy-3-methoxyphenyl)-5-(5-methylpyridin-2-ylamino)decan-3-one

1-(4-hydroxy-3-methoxyphenyl)-5-(5-methylpyridin-2-ylamino)decan-3-one

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide at 20℃; for 24h; Michael Addition;50%
Conditions
ConditionsYield
With benzyltri(n-butyl)ammonium chloride; potassium hydroxide In chloroform; water at 20℃; for 6.5h;44%
5-bromouracil
51-20-7

5-bromouracil

[6]-shogaol
555-66-8

[6]-shogaol

5-bromo-1-(1-(4-hydroxy-3-methoxyphenyl)-3-oxodecan-5-yl)-pyrimidine-2,4-(1H,3H)-dione

5-bromo-1-(1-(4-hydroxy-3-methoxyphenyl)-3-oxodecan-5-yl)-pyrimidine-2,4-(1H,3H)-dione

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide at 20℃; for 24h; Michael Addition;43%
[6]-shogaol
555-66-8

[6]-shogaol

5-(6-amino-9H-purin-9-yl)-1-(4-hydroxy-3-methoxyphenyl)decan-3-one
1311378-31-0

5-(6-amino-9H-purin-9-yl)-1-(4-hydroxy-3-methoxyphenyl)decan-3-one

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide at 20℃; for 24h; Michael Addition;38%
With caesium carbonate In methanol; water at 20℃; for 72h; Michael-type reaction;36%
diethyl ether
60-29-7

diethyl ether

[6]-shogaol
555-66-8

[6]-shogaol

platinum black

platinum black

dihydroshogaol

dihydroshogaol

Conditions
ConditionsYield
Hydrogenation;
[6]-shogaol
555-66-8

[6]-shogaol

2-methoxy-4-(5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)phenyl methanesulfonate

2-methoxy-4-(5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)phenyl methanesulfonate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dimethyl sulfoxide / 24 h / 20 °C
2: triethylamine / dichloromethane / 2 h / 0 - 20 °C
View Scheme
[6]-shogaol
555-66-8

[6]-shogaol

2-methoxy-4-(5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)phenyl 4-methylbenzenesulfonate

2-methoxy-4-(5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)phenyl 4-methylbenzenesulfonate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dimethyl sulfoxide / 24 h / 20 °C
2: triethylamine / dichloromethane / 2 h / 0 - 20 °C
View Scheme
[6]-shogaol
555-66-8

[6]-shogaol

2-methoxy-4-(5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)phenyl 6-chloronicotinate

2-methoxy-4-(5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)phenyl 6-chloronicotinate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dimethyl sulfoxide / 24 h / 20 °C
2: triethylamine / dichloromethane / 2 h / 0 - 20 °C
View Scheme
[6]-shogaol
555-66-8

[6]-shogaol

C38H42N2O9

C38H42N2O9

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dimethyl sulfoxide / 24 h / 20 °C
2: triethylamine / dichloromethane / 2 h / 0 - 20 °C
View Scheme
[6]-shogaol
555-66-8

[6]-shogaol

4-(5-(3-(furan-2-carbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)-2-methoxyphenyl furan-2-carboxylate

4-(5-(3-(furan-2-carbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-oxodecyl)-2-methoxyphenyl furan-2-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dimethyl sulfoxide / 24 h / 20 °C
2: triethylamine / dichloromethane / 2 h / 0 - 20 °C
View Scheme

555-66-8Relevant articles and documents

6-Gingerol and Semisynthetic 6-Gingerdione Counteract Oxidative Stress Induced by ROS in Zebrafish

Manjunathan, Tamilvelan,Guru, Ajay,Arokiaraj, Jesu,Gopinath, Pushparathinam

, (2021/11/03)

6-Gingerol (1) is one of the major components in ginger and developing new synthetic methodologies could bring semisynthetic analogs with improved therapeutic properties. Towards this, multigram scale isolation of 6-gingerol with excellent purity was optimized using a simple and robust extraction, followed by column purification. Synthesis of 6-gingerdione, 7 from 6-gingerol was then achieved through selective –OTBDMS protection, DMP oxidation and deprotection reaction sequence for the first time. Compounds 1, 7 and 8 (dehydrozingerone) exhibited excellent cell-free antioxidant properties in DPPH, ABTS, superoxide radical scavenging assay and H2O2 assay at 10–50 μM concentrations. The hemolytic study suggests that up to 50 μM, all three compounds did not exhibit toxicity to human erythrocytes. When H2O2 treated zebrafish larvae groups (96hpf) were exposed to compounds 1, 7 and 8, it increases the SOD (19, 19.1 and 18.7 U/mg protein), CAT (18.1, 16.5, and 15.8 μmol/mg levels and decreases the lipid peroxidation level (13, 15 and 18 nmol/mg protein), respectively. In vivo ROS levels and degree of cell death were studied using DCFDA and Acridine orange assays. Compounds 1, 7 and 8 decreases the ROS and cell death level significantly. Taken together, compounds 1, 7 and 8 exhibit excellent antioxidant properties, counteract H2O2 induced oxidative stress, reduces cell death in zebrafish larvae.

First enantioselective synthesis of gingesulfonic acids and unequivocal determination of their absolute stereochemistry

Adamo, Mauro F. A.,Bencivenni, Grazia,Gillick-Healy, Malachi W.,Kelly, Brian G.,Moccia, Maria,Ravelli, Andrea

supporting information, p. 1091 - 1094 (2020/02/22)

Herein we report the first organocatalysed enantioselective synthesis of gingesulfonic acids and shogasulfonic acids via a mild and convenient aminothiourea-catalysed conjugate addition of bisulfite to the olefin moiety of α,β-unsaturated carbonyls - a technology previously reported by us. A series of optically active naturally occurring sulfonic acids are prepared in their natural and unnatural configurations, and their absolute configurations are unequivocally confirmed by single crystal X-ray diffractometry.

Preparation method of (E)-1-(4-hydroxy-3-methoxyphenyl)-4-ene-3-decalone

-

, (2018/07/15)

The invention discloses a preparation method of (E)-1-(4-hydroxy-3-methoxyphenyl)-4-ene-3-decalone and relates to the field of medicinal chemistry. The method comprises the steps as follows: 1) 4-(4-hydroxy-3-methoxyphenyl)-2-butanone is dissolved in a halogenated hydrocarbon solvent, pyrrolidine or piperidine is added at the room temperature, and the mixture reacts for 15-120 min; 2) a halogenated hydrocarbon solution of n-hexaldehyde is added, and the mixture reacts for 2-24 h; 3) an inorganic base solution is added, the mixture reacts for 1-24 h, aftertreatment is performed, and a compoundshown in formula (1) is prepared. Reactions at the room temperature are conducted with inorganic base and other weak bases, and the total yield is 78% or above. The method has mild reaction conditionsand is convenient to operate and suitable for industrial production.

Kinetic Resolution of β-Hydroxy Carbonyl Compounds via Enantioselective Dehydration Using a Cation-Binding Catalyst: Facile Access to Enantiopure Chiral Aldols

Paladhi, Sushovan,Hwang, In-Soo,Yoo, Eun Jeong,Ryu, Do Hyun,Song, Choong Eui

supporting information, p. 2003 - 2006 (2018/04/16)

A practical and highly enantioselective nonenzymatic kinetic resolution of racemic β-hydroxy carbonyl (aldol) compounds through enantioselective dehydration process was developed using a cation-binding Song's oligoethylene glycol (oligoEG) catalyst with p

Rapid synthesis method of shogaol compounds

-

Paragraph 0031; 0032, (2018/03/26)

The invention relates to a rapid synthesis method of shogaol compounds. The specific reaction route is shown in the description. Compounds in formula (4) are obtained from dehydrozingerone and carbonic acid diester under the action of a base, dissolved in an organic solvent and subjected to hydrogenation reduction, key intermediate compounds shown in formula (5) are obtained and react with aliphatic aldehydes under the action of the base, and target compounds 6-shogaol in formula (1), 8-shogaol in formula (2) and 10-shogaol in formula (3) are obtained. The rapid synthesis method has the advantages that reaction yield is high, reaction conditions are mild, operation is simple and environment-friendliness is realized, and has good industrial application prospect.

Synthesis, docking, cytotoxicity, and LTA4H inhibitory activity of new gingerol derivatives as potential colorectal cancer therapy

El-Naggar, Mai H.,Mira, Amira,Abdel Bar, Fatma M.,Shimizu, Kuniyoshi,Amer, Mohamed M.,Badria, Farid A.

, p. 1277 - 1285 (2017/02/05)

Leukotriene A4 hydrolase (LTA4H) is a proinflammatory enzyme that generates the inflammatory mediator leukotriene which may play an important role in chronic inflammation associated carcinogenesis. [6]-gingerol, the major bioactive compound of Zingiber officinale, is a potential inhibitor of LTA4H, a highly expressed enzyme in colorectal carcinoma. Eighteen compounds; seven of natural origin (including [4]-, [6]-, [8]-, and [10]-gingerol), five new and six known semi-synthesized [6]-gingerol derivatives were examined using docking, in vitro cytotoxicity against human colon cancer cells (HCT-116) and LTA4H aminopeptidase and epoxide hydrolase inhibitory studies. Methyl shogoal (D8) showed to be the most potent compound against HCT-116 cells (IC50; 1.54?μM). Remarkably, D8 proved to be non-cytotoxic to normal cells; (TIG-1) and (HF-19) with high selective index (SI; 52.3). Furthermore [6]-gingerol derivatives showed potent LTA4H inhibitory activities in comparison to the universal positive controls (bestatin and 4BSA). Among the natural gingerols, [10]-gingerol (N3) exhibited the highest LTA4H aminopeptidase and epoxide hydrolase inhibitory activities with IC50; 21.59 and 15.24?μM, respectively. Meanwhile, methyl shogoal (D8) and 4′-O-prenyl-[6]-gingerol (D10) retained the highest inhibition with IC50; 4.92 and 3.01?μM, for aminopeptidase, and 11.27 and 7.25?μM for epoxide hydrolase activities, respectively.

Influence of side chain structure changes on antioxidant potency of the [6]-gingerol related compounds

Lu, Dong-Liang,Li, Xiu-Zhuang,Dai, Fang,Kang, Yan-Fei,Li, Yan,Ma, Meng-Meng,Ren, Xiao-Rong,Du, Gao-Wei,Jin, Xiao-Ling,Zhou, Bo

, p. 191 - 197 (2014/06/24)

[6]-Gingerol and [6]-shogaol are the major pungent components in ginger with a variety of biological activities including antioxidant activity. To explore their structure determinants for antioxidant activity, we synthesized eight compounds differentiated by their side chains which are characteristic of the C1-C2 double bond, the C4-C5 double bond or the 5-OH, and the six- or twelve-carbon unbranched alkyl chain. Our results show that their antioxidant activity depends significantly on the side chain structure, the reaction mediums and substrates. Noticeably, existence of the 5-OH decreases their formal hydrogen-transfer and electron-donating abilities, but increases their DNA damage- and lipid peroxidation-protecting abilities. Additionally, despite significantly reducing their DNA strand breakage-inhibiting activity, extension of the chain length from six to twelve carbons enhances their anti-haemolysis activity.

Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators

Morera, Enrico,De Petrocellis, Luciano,Morera, Ludovica,Moriello, Aniello Schiano,Nalli, Marianna,Di Marzo, Vincenzo,Ortar, Giorgio

supporting information; experimental part, p. 1674 - 1677 (2012/04/04)

In order to explore the structural determinants for the TRPV1 and TRPA1 agonist properties of gingerols, aseries of nineteen analogues (1b-5) of racemic [6]-gingerol (1a) was synthesized and tested on TRPV1 and TRPA1 channels. The exploration of the structure-activity relationships, by modulating the three pharmacophoric regions of [6]-gingerol, led to the identification of some selective TRPV1 agonists/desensitizers of TRPV1 channels (3a, 3f, and 4) and of some full TRPA1 antagonists (2c, 2d, 3b, and 3d). 2011 Elsevier Ltd. All rights reserved.

Protection-, salt-, and metal-free syntheses of [n]-shogaols by use of dimethylammonium dimethyl carbamate (DIMCARB) without protecting groups

Mase, Nobuyuki,Kitagawa, Norihiko,Takabe, Kunihiko

experimental part, p. 93 - 96 (2010/07/16)

Shogaols, the pungent principle of ginger, exhibit interesting bioactivities. Practical preparation of shogaols is highly desired. Here we report the protection/deprotection-, salt-, and metalfree synthesis of shogaol in three steps by use of dimethylammonium dimethyl carbamate (DIMCARB), in which DIMCARB smoothly promoted Mannich-type condensation of the ketone donor with the aldehyde acceptor through the iminium cation intermediate. Georg Thieme Verlag Stuttgart.

PROCESS FOR PRODUCING SHOGAOL AND INTERMEDIATES FOR THE SYNTHESIS THEREOF

-

Page 8, (2010/02/10)

In accordance with the invention, an industrial process for producing shogaols useful in the fields of for example foods, flavor, pharmaceutical products, qui-pharmaceutical products and cosmetics can be provided. The invention relates to novel intermediates represented by the following general formula and a process for producing shogaols from the intermediates. In accordance with the invention, shogaols can readily be produced, of which mass production has been difficult because shogaols have been produced only by the extraction process from a natural ginger. Intermediates; (in the formula (1), R1 represents hydrogen atom or methyl group; R2 represents optionally branched alkyl group with one to 18 carbon atoms; R3 and R4 each independently represents hydrogen atom, a lower alkyl group or a protective group of the phenolic hydroxyl group; A represents an alkylene group with one to 4 carbon atoms; and X represents benzenesulfonyl group or toluenesulfonyl group.)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 555-66-8